Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2008-03-19
2011-12-06
Zucker, Paul A (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S153000
Reexamination Certificate
active
08071643
ABSTRACT:
A pleuromutilin derivative compound of general formula (I)
REFERENCES:
patent: 2003/0162831 (2003-08-01), Ascher et al.
patent: 4023848 (1992-01-01), None
patent: 02/04414 (2002-01-01), None
patent: 03/090740 (2003-06-01), None
patent: 03/082260 (2003-09-01), None
patent: 2007/000004 (2007-01-01), None
patent: 2007/014409 (2007-02-01), None
Clinical and Laboratory Standards Institute (CLSI, former NCCLS) Document M7-A7 vol. 26, No. 2: “Methods for dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically—Approved Standard; Seventh Edition”, Jan. 2006.
Clinical and Laboratory Standards Institute (CLSI, former NCCLS), Document , M11-A6, vol. 24, No. 2: “Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria—Approved Standard; Sixth Edition” 2004.
H. Berner, et al “Synthese AB-Trans-Anellierter Derivate DES Tricyclischen Diterpens Pleuromutilin Durch Intramolekulare 1,5-Hydrid-Verschiebung” Tetrahedron, vol. 36, No. 12-l, pp. 1807 to 1811, Pergamon Press Ltd., 1980, Great Britain.
Elena Gomez-Sanchez, et al “Synthesis and transformations of alkyl N-(1-cyclohex-3-enyl)carbamates prepared from cyclohex-3-ene carboxylic acid via Curtius rearrangement” Tetrahedron vol. 61, 2005, pp. 1207-1219.
Judith C. Amburgey, et al “Small Molecule Analogs of Phospholipid-Metal Ion Binding Sites: Synthesis and Molecular Modeling of Cyclohexane-1,2,4-triol Trisphosphates” Bioorganic Chemistry, 22, 1994, pp. 172-197.
Peter Kapferer, et al “Electrophilic Bromination of N-Acylated Cyclohex-3-en-1-amines: Synthesis of 7-Azanorbornanes” Helvetica Chimica Acta, vol. 87, 2004, pp. 2764-2789.
Peter O'Brien, et al “cis- and trans-Stereoselective Epoxidation of N-Protected 2-Cyclohexen-1-ylamines” Organic Letters, vol. 5, No. 26, 2003, pp. 4955-4957.
Liming Zhang, et al “Stereocontrolled Synthesis of Kelsoene by the Homo-Favorkii Rearrangement” Organic Letters, vol. 4, No. 21, 2002, pp. 3755-3758.
Yashwant D. Vankar, et al “Chiral Acetals in Organic Synthesis: Regioselective Synthesis of 2—and 3-Hydroxy Acetals from 2,3-Olefinic Acetals. Reinvestigation and Further Applications” Tetrahedron, vol. 50, No. 7, 1994, pp. 11057-11078.
Helmut Egger, et al “New Pleuromutilin Derivatives with Enhanced Antimicrobial Activity” The Journal of Antibiotics, vol. XXIX, No. 9, 1976, pp. 915-927.
B. Raju, et al “Conformationally restricted analogs of deoxynegamycin” Bioorganic & Medicinal Chemistry Letters, 14, 2004, pp. 3103-3107.
Elliot N. Marvell, et al “Products of Acetolysis of 3-(3-Cyclohexenyl)propyl and 4-(3-Cyclohexenyl—butyl p-Toluenesulfonates” Journal of Organic Chemistry, vol. 33, No. 7, Jul. 1968, pp. 2291-2993.
Badegruber Rudolf
Bulusu Atchyuta Rama Chandra Murty
Ferencic Mathias
Heilmayer Werner
Mang Rosemarie
Nabriva Therapeutics AG
Workman Nydegger
Zucker Paul A
LandOfFree
Pleuromutilin derivatives for the treatment of diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pleuromutilin derivatives for the treatment of diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pleuromutilin derivatives for the treatment of diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4312132